• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MVR:GR

13.350 EUR 0.041 0.31%

As of 03:05:05 ET on 08/29/2014.

Snapshot for Medivir AB (MVR)

Open: 13.390 Day's Range: 13.350 - 13.515 Volume: 0
Previous Close: 13.391 52wk Range: 8.714 - 16.420 1-Yr Rtn: +50.05%

Stock Chart for MVR

No chart data available.
  • MVR:GR 13.350
  • 1D
  • 1M
  • 1Y
13.391
Interactive MVR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MVR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 3.0973
Relative P/E vs. DAX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) 39.5580
Est. PEG Ratio -
Market Cap (M EUR) 429.88
Shares Outstanding (M) 30.60
30 Day Average Volume 20
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/20/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MVR

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for MVR

Medivir AB is a medical research company. The Company develops new drugs and pharmaceutical compounds based on proteases and polymerases as target enzymes. Medivir focuses on infectious and immunological diseases including projects against HIV, jaundice, shingles, multiple sclerosis, and rheumatoid arthritis. The Company is located in Huddinge, Sweden and Cambridge, United Kingdom.

Maris HartmanisPresident/CEOChristina KassbergExec VP:Finance & Administration
Paul WallaceExec VP:Business DevelopmentRein PiirExec VP:Corporate Affairs
More Company Profile & Key Executives for MVR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil